CVS Caremark CEO Expects Bid for Longs To Be Approved
On Thursday, CVS Caremark CEO Tom Ryan said he expects Longs Drug Stores shareholders to approve his company's $2.9 billion offer to purchase Longs despite pressure from some to increase its bid. For the deal to pass, CVS needs to obtain 66% of Longs' diluted common shares.
- "CVS Chief Expects Longs Shareholders To Accept $2.9B Purchase Price" (Silicon Valley/San Jose Business Journal, 9/4).